Cargando…
Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data
Cancer mortality has improved due to earlier detection via screening, as well as due to novel cancer therapies such as tyrosine kinase inhibitors and immune checkpoint inhibitions. However, similarly to older cancer therapies such as anthracyclines, these therapies have also been documented to cause...
Autores principales: | Kwan, Jennifer M., Oikonomou, Evangelos K., Henry, Mariana L., Sinusas, Albert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964995/ https://www.ncbi.nlm.nih.gov/pubmed/35369354 http://dx.doi.org/10.3389/fcvm.2022.829553 |
Ejemplares similares
-
Commentary: “Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data”
por: Sun, Louise Y., et al.
Publicado: (2023) -
Radiotherapy-Induced Cardiotoxicity: The Role of Multimodality Cardiovascular Imaging
por: Podlesnikar, Tomaž, et al.
Publicado: (2022) -
Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity
por: Feher, Attila, et al.
Publicado: (2022) -
Artificial Intelligence Advancements in the Cardiovascular Imaging of Coronary Atherosclerosis
por: Covas, Pedro, et al.
Publicado: (2022) -
Artificial Intelligence Based Multimodality Imaging: A New Frontier in Coronary Artery Disease Management
por: Maragna, Riccardo, et al.
Publicado: (2021)